rs1553803217
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_053025.4(MYLK):c.3277_3278delAG(p.Ser1093ProfsTer31) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_053025.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
The c.3277_3278delAG variant, located in coding exon 15 of the MYLK gene, results from a deletion of two nucleotides at nucleotide positions 3277 to 3278, causing a translational frameshift with a predicted alternate stop codon (p.S1093Pfs*31). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Although loss of function alterations in MYLK have been associated with thoracic aortic aneurysms and dissections (TAAD) in two studies (Wang L et al. Am J Hum Genet. 2010;87(5):701-7; Hannuksela M et al. BMC Med Genet. 2016;17(1):61), loss of function of MYLK has not been clearly established as a mechanism of disease. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at